Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease

Kirsten Stewart; Chris RuiWen Kuo; Rory Chan; Brian Lipworth

doi:10.1111/all.16249

Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease

Kirsten Stewart
, Chris RuiWen Kuo
, Rory Chan
, Brian Lipworth (Lead / Corresponding author)

MED Respiratory Medicine and Gastroenterology

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

99 Downloads (Pure)

Original language	English
Pages (from-to)	2871-2873
Number of pages	3
Journal	Allergy
Volume	79
Issue number	10
Early online date	20 Jul 2024
DOIs	https://doi.org/10.1111/all.16249
Publication status	Published - Oct 2024

Access to Document

10.1111/all.16249Licence: CC BY

Final Published VersionFinal published version, 466 KBLicence: CC BY

Cite this

@article{2fce7efd243f4de6866ac6f1b07503cc,

title = "Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease",

author = "Kirsten Stewart and Kuo, \{Chris RuiWen\} and Rory Chan and Brian Lipworth",

note = "This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.{\textcopyright} 2024 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley \& Sons Ltd.",

year = "2024",

month = oct,

doi = "10.1111/all.16249",

language = "English",

volume = "79",

pages = "2871--2873",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease

AU - Stewart, Kirsten

AU - Kuo, Chris RuiWen

AU - Chan, Rory

AU - Lipworth, Brian

N1 - This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.© 2024 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

PY - 2024/10

Y1 - 2024/10

UR - https://www.scopus.com/pages/publications/85198977645

U2 - 10.1111/all.16249

DO - 10.1111/all.16249

M3 - Letter

C2 - 39033313

SN - 0105-4538

VL - 79

SP - 2871

EP - 2873

JO - Allergy

JF - Allergy

IS - 10

ER -

Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease

Access to Document

Other files and links

Cite this